Join, Follow & Connect

Healthcare Business News

Novartis drug reviewed after 11 deaths reported

By Bloomberg Businessweek

Posted: January 20, 2012 - 2:30 pm ET

Tags:

European and U.S. regulators are reviewing Novartis’ Gilenya pill for multiple sclerosis after reports of 11 deaths among patients who took the drug.

Advertisement | View Media Kit

Today's Headlines

Share your opinion. Send a letter to the Editor or Post a comment below.

Loading comments...

Search ModernHealthcare.com:

Modern Healthcare is part of Crain Communications, Inc., one of the largest privately owned business publishers in the U.S., with more than 27 leading business, trade and consumer publications and related websites in North America, Europe and Asia. For more information, visit Crain.com
Advertising Age Automobilwoche Automotive News Automotive News Europe Autoweek BtoB	Business Insurance Crain's Chicago Business Crain's Cleveland Business Crain's Detroit Business Crain's New York Business Creativity	European Plastics News European Rubber Journal InvestmentNews Media Business Modern Physician Pensions & Investments	Plastics News Plastics News China Plastics & Rubber Weekly Rubber & Plastics News shopautoweek.com Staffing Industry Analysts	TelevisionWeek Tire Business Urethanes Technology International Waste & Recycling News Workforce